(Q58999704)

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Flavivirus genome organization, expression, and replication

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Construction of intertypic chimeric dengue viruses by substitution of structural protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Human skin Langerhans cells are targets of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Mutation of putative N-linked glycosylation sites in Japanese encephalitis virus premembrane and envelope proteins enhances humoral immunity in BALB/C mice after DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Dengue virus type 2 infects human endothelial cells through binding of the viral envelope glycoprotein to cell surface polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

A Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Coxsackievirus targets proliferating neuronal progenitor cells in the neonatal CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Inflammation: a new candidate in modulating adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Unravelling the neuropathogenesis of Japanese encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Past, Present, and Future of Japanese Encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Measles virus neurovirulence and host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Tumor necrosis factor receptor-1-induced neuronal death by TRADD contributes to the pathogenesis of Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

A model to study neurotropism and persistency of Japanese encephalitis virus infection in human neuroblastoma cells and leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Neuropathogenesis of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Adult neurogenesis: from precursors to network and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Adult neurogenesis and functional plasticity in neuronal circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

HIV-1 promotes quiescence in human neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Mosquito feeding modulates Th1 and Th2 cytokines in flavivirus susceptible mice: an effect mimicked by injection of sialokinins, but not demonstrated in flavivirus resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Natural antibodies and complement link innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

In VitroT-Cell Proliferative Response to the Flavivirus, West Nile

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

A single gene controls resistance to Japanese encephalitis virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Protective Mechanisms Induced by a Japanese Encephalitis Virus DNA Vaccine: Requirement for Antibody but Not CD8+ Cytotoxic T-Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Japanese encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Kinetics of cytokine profile during intraperitoneal inoculation of Japanese encephalitis virus in BALB/c mice model

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

An insufficient anti-inflammatory cytokine response in mouse brain is associated with increased tissue pathology and viral load during Japanese encephalitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Innate immune recognition of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Japanese encephalitis virus infection decrease endogenous IL-10 production: correlation with microglial activation and neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Multifront assault on antigen presentation by Japanese encephalitis virus subverts CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

21 January 2018

Japanese encephalitis

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Comparison of a dipstick enzyme-linked immunosorbent assay with commercial assays for detection of Japanese encephalitis virus-specific IgM antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Development and evaluation of a rapid IgM capture ELISA (JEV-Chex) for the diagnosis of Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Immune enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms involved

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Antibody-mediated early death in vivo after infection with yellow fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

RNA interference in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

RNA silencing as a plant immune system against viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Long-distance movement, virulence, and RNA silencing suppression controlled by a single protein in hordei- and potyviruses: complementary functions between virus families.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

siRNA-directed inhibition of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

RNA interference--a new weapon against HIV and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Protective T cell-independent antiviral antibody responses are dependent on complement

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

The complement system in regulation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Human complement regulators: a major target for pathogenic microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Molecular organization and function of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Virus complement evasion strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

A Japanese Encephalitis Virus Peptide Present on Johnson Grass Mosaic Virus-Like Particles Induces Virus-Neutralizing Antibodies and Protects Mice against Lethal Challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Immune response to synthetic peptides of dengue prM protein

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Japanese encephalitis virus NS2B-NS3 protease induces caspase 3 activation and mitochondria-mediated apoptosis in human medulloblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Structure-based virtual screening for novel inhibitors of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Evasion of innate and adaptive immunity by flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Localizations of NS3 and E proteins in mouse brain infected with mutant strain of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Association of Japanese encephalitis virus NS3 protein with microtubules and tumour susceptibility gene 101 (TSG101) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Mice with different susceptibility to Japanese encephalitis virus infection show selective neutralizing antibody response and myeloid cell infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Flavivirus-induced antibody cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Induction of virus-specific neutralizing immune response against West Nile and Japanese encephalitis viruses by chimeric peptides representing T-helper and B-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Chronic progressive encephalitis occurring 13 years after Russian spring-summer encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

New Japanese encephalitis vaccines: alternatives to production in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains)

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Protection against Japanese encephalitis by inactivated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Genome sequence and attenuating mutations in West Nile virus isolate from Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Genomic and antigenic characterization of the newly emerging Chinese duck egg-drop syndrome flavivirus: genomic comparison with Tembusu and Sitiawan viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

IC51 Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Current use and development of vaccines for Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Change in Japanese Encephalitis Virus Distribution,Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

A high rate of neurological complications following Semple anti-rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Optimizing the stability of single-chain proteins by linker length and composition mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Evaluation of Extracellular Subviral Particles of Dengue Virus Type 2 and Japanese Encephalitis Virus Produced bySpodoptera frugiperdaCells for Use as Vaccine and Diagnostic Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

DNAzyme-mediated inhibition of Japanese encephalitis virus replication in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396

Development and Application of a Reverse Genetics System for Japanese Encephalitis Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2013%2F830396